Citation Impact
Citing Papers
PDGFRA Activating Mutations in Gastrointestinal Stromal Tumors
2003 StandoutScience
Kinase Mutations and Imatinib Response in Patients With Metastatic Gastrointestinal Stromal Tumor
2003 Standout
The AKT-mTOR pathway plays a critical role in the development of leiomyosarcomas
2007 Standout
Estrogen Receptor Status by Immunohistochemistry Is Superior to the Ligand-Binding Assay for Predicting Response to Adjuvant Endocrine Therapy in Breast Cancer
1999 Standout
Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer
2009 Standout
The relationship between prognostic and predictive factors in the management of breast cancer
1998
Hypoxia-Inducible Factors and the Response to Hypoxic Stress
2010 Standout
American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast Cancer
2007 Standout
Gene Expression and Benefit of Chemotherapy in Women With Node-Negative, Estrogen Receptor–Positive Breast Cancer
2006 Standout
Health effects of quercetin: From antioxidant to nutraceutical
2008 Standout
Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis
2007 Standout
Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment
2012 Standout
Cell Signaling by Receptor Tyrosine Kinases
2010 Standout
Molecular characterisation of soft tissue tumours: a gene expression study
2002 Standout
Molecular mechanisms underlying human synovial sarcoma development
2000
Genetic instabilities in human cancers
1998 StandoutNature
New Substructure Filters for Removal of Pan Assay Interference Compounds (PAINS) from Screening Libraries and for Their Exclusion in Bioassays
2010 Standout
Incidence of Sarcoma Histotypes and Molecular Subtypes in a Prospective Epidemiological Study with Central Pathology Review and Molecular Testing
2011 Standout
Epithelial-Mesenchymal Transitions
2004 Standout
Small GTPase Rac1: Structure, Localization, and Expression of the Human Gene
2000
EMT Transition States during Tumor Progression and Metastasis
2018 Standout
Immunohistochemical analysis of NY-ESO-1 antigen expression in normal and malignant human tissues
2001
Soft-Tissue Sarcomas in Adults
2005 Standout
Complex networks orchestrate epithelial–mesenchymal transitions
2006 Standout
Contribution of molecular genetic data to the classification of sarcomas
2000
Macrophage Diversity Enhances Tumor Progression and Metastasis
2010 Standout
Epithelial to Mesenchymal Transition in Human Breast Cancer Can Provide a Nonmalignant Stroma
2003
The biochemistry and medical significance of the flavonoids
2002 Standout
Immunohistochemistry in the diagnosis of soft tissue tumours
2003
Immunity, Inflammation, and Cancer
2010 Standout
Molecular requirements for epithelial–mesenchymal transition during tumor progression
2005 Standout
Classes of c-KIT activating mutations: proposed mechanisms of action and implications for disease classification and therapy
2001
Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm
2010 Standout
The roles of PTEN in development, physiology and tumorigenesis in mouse models: a tissue-by-tissue survey
2008 StandoutNobel
Avelumab in patients with chemotherapy-refractory metastatic Merkel cell carcinoma: a multicentre, single-group, open-label, phase 2 trial
2016 Standout
Portrait of PTEN: Messages from mutant mice
2008 StandoutNobel
Primary vs. secondary neoplasia-associated chromosomal abnormalities—balanced rearrangements vs. genomic imbalances?
1996
A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer
2004 Standout
Mutations in Exons 9 and 13 of KIT Gene Are Rare Events in Gastrointestinal Stromal Tumors
2000
Met, metastasis, motility and more
2003 Standout
Monophasic Fibrous and Poorly Differentiated Synovial Sarcoma
2002
Microenvironmental regulation of metastasis
2008 Standout
The Ki-67 protein: From the known and the unknown
2000 Standout
Smart drugs: Tyrosine kinase inhibitors in cancer therapy
2002
Medicinal Plants of the Russian Pharmacopoeia; their history and applications
2014
Fibroblasts in cancer
2006 Standout
Expression of fatty acid synthase (FAS) as a predictor of recurrence in stage I breast carcinoma patients
1996
Microenvironmental regulation of tumor progression and metastasis
2013 Standout
The prognostic landscape of genes and infiltrating immune cells across human cancers
2015 Standout
A Conditional Mouse Model of Synovial Sarcoma: Insights into a Myogenic Origin
2007 StandoutNobel
Cathepsin-D in primary breast cancer: prognostic evaluation involving 2810 patients
1998
Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability
2009 Standout
Oestrogen receptor, progesterone receptor, pS2, ERD5, HSP27 and cathepsin D in invasive ductal breast carcinomas
1993
No significant predictive value of c- erbB-2 or p53 expression regarding sensitivity to primary chemotherapy or radiotherapy in breast cancer
1998
Fatty Acid Synthase (Fas) Predictive Strength in Poorly Differentiated Early Breast Carcinomas
1999
Association between keratin and vimentin expression, malignant phenotype, and survival in postmenopausal breast cancer patients.
1999
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications
2001 Standout
The Three Es of Cancer Immunoediting
2004 Standout
Integrated NY-ESO-1 antibody and CD8+T-cell responses correlate with clinical benefit in advanced melanoma patients treated with ipilimumab
2011 StandoutNobel
Biology of Gastrointestinal Stromal Tumors
2004 Standout
Distinct Role of Macrophages in Different Tumor Microenvironments
2006 Standout
Flavonoid (Myricetin, Quercetin, Kaempferol, Luteolin, and Apigenin) Content of Edible Tropical Plants
2001 Standout
The Effects of Plant Flavonoids on Mammalian Cells:Implications for Inflammation, Heart Disease, and Cancer
2000 Standout
Critical nodes in signalling pathways: insights into insulin action
2006 Standout
Design, Synthesis, Cytoselective Toxicity, Structure–Activity Relationships, and Pharmacophore of Thiazolidinone Derivatives Targeting Drug-Resistant Lung Cancer Cells
2008
Changes in Cytoskeletal Protein Composition Indicative of an Epithelial-Mesenchymal Transition in Human Micrometastatic and Primary Breast Carcinoma Cells
2005
Antimicrobial activity of flavonoids
2005 Standout
CTLA-4 blockade enhances polyfunctional NY-ESO-1 specific T cell responses in metastatic melanoma patients with clinical benefit
2008 StandoutNobel
Flavonoids, a class of natural products of high pharmacological potency
1983
The Traditional Medicine and Modern Medicine from Natural Products
2016 Standout
Detection of the synovial sarcoma translocation t(X;18) (SYT;SSX) in paraffin-embedded tissues using reverse transcriptase-polymerase chain reaction: A reliable and powerful diagnostic tool for pathologists
2001
Prognostic significance of tumor cell proliferation rate as determined by the MIB-1 antibody in breast carcinoma: its relationship with vimentin and p53 protein.
1996
Impact of SYT-SSX fusion type on the clinical behavior of synovial sarcoma: a multi-institutional retrospective study of 243 patients.
2002
Chemotherapy in Neuroendocrine/Merkel Cell Carcinoma of the Skin: Case Series and Review of 204 Cases
2000
The epithelial–mesenchymal transition: new insights in signaling, development, and disease
2006 Standout
Works of A Szadowska being referenced
[Synthesis of N,N-diethylaminoethyl ethers of flavanone oximes and the study of their antihistaminic and spasmolytic properties].
1979
Neuroendocrine (Merkel cell) carcinoma of the skin: a clinico‐morphological study of 13 cases
1989
Clinical impact of molecular and cytogenetic findings in synovial sarcoma
2001
Serial transplants of DMBA-induced mammary tumors in Fischer rats as model system for human breast cancer: V.Myoepithelial-mesenchymal conversion during passaging as possible cause for modulation of pineal-tumor interaction
2000
Cytogenetic findings in malignant peripheral nerve sheath tumors
1995
[Pharmacological action of the galenicals and flavonoids isolated from Helichrysum arenarium].
1962
Cathepsin D in invasive ductal NOS breast carcinoma as defined by immunohistochemistry. No correlation with survival at 5 years.
1992
Nuclear p53 protein accumulates preferentially in medullary and high-grade ductal but rarely in lobular breast carcinomas.
1993
[Synthesis of benzylidene derivatives of 3-o, 3-m and 3-p-chlorophenylhydantoin and the study of their anticonvulsant action].
1984
Detection of the SYT-SSX fusion transcripts in formaldehyde-fixed, paraffin-embedded tissue: a reverse transcription polymerase chain reaction amplification assay useful in the diagnosis of synovial sarcoma.
1998
A comparative study of P53/MDM2 genes alterations and P53/MDM2 proteins immunoreactivity in soft-tissue sarcomas.
1999
p53 protein and vimentin m invasive ductal NOS breast carcinoma—relationship with survival and sites of metastases
1994
NONRANDOM SECONDARY CHROMOSOME-ABERRATIONS IN SYNOVIAL SARCOMAS WITH T(X-18)
1995